C Guilleminault, J P Cathala, P Castaigne. Show Affiliations »
Abstract
Entities: Chemical Species
Mesh: See more » 5-Hydroxytryptophan/administration & dosage5-Hydroxytryptophan/therapeutic useAdultBrain Diseases/complicationsBrain Diseases/physiopathologyBrain Stem/physiopathologyElectroencephalographyElectromyographyElectrooculographyHumansHydroxyindoleacetic Acid/cerebrospinal fluidMalePhenylacetates/cerebrospinal fluidSerotonin/metabolismSleep/drug effectsSleep StagesSleep Wake Disorders/drug therapySleep Wake Disorders/etiologySleep Wake Disorders/metabolismSleep Wake Disorders/physiopathology
Substances: See more » PhenylacetatesSerotoninHydroxyindoleacetic Acid5-Hydroxytryptophan
Year: 1973 PMID: 4119531 DOI: 10.1016/0013-4694(73)90045-x
Source DB: PubMed Journal: Electroencephalogr Clin Neurophysiol ISSN: 0013-4694